Li, W., Shenkar, R., Detter, M. R., Moore, T., Benavides, C., Lightle, R., … Awad, I. A. (2021). Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. The Journal of Clinical Investigation, 131(19), e154909. https://doi.org/10.1172/jci154909

Li, Wenqing, Robert Shenkar, Mathew R. Detter, Thomas Moore, Christian Benavides, Rhonda Lightle, Romuald Girard, et al. “Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.” The Journal of Clinical Investigation 131, no. 19 (October 2021): e154909. https://doi.org/10.1172/jci154909.

Li W, Shenkar R, Detter MR, Moore T, Benavides C, Lightle R, et al. Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. The Journal of clinical investigation. 2021 Oct;131(19):e154909.

Li, Wenqing, et al. “Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.” The Journal of Clinical Investigation, vol. 131, no. 19, Oct. 2021, p. e154909. Epmc, doi:10.1172/jci154909.

Li W, Shenkar R, Detter MR, Moore T, Benavides C, Lightle R, Girard R, Hobson N, Cao Y, Li Y, Griffin E, Gallione C, Zabramski JM, Ginsberg MH, Marchuk DA, Awad IA. Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. The Journal of clinical investigation. 2021 Oct;131(19):e154909.